Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP1216409.RABMGkE9CXg1Ef04UqJCJ03AeJv8Ap5U6sfB6kNnxvcfw130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP1216409.RABMGkE9CXg1Ef04UqJCJ03AeJv8Ap5U6sfB6kNnxvcfw130_assertion type Assertion NP1216409.RABMGkE9CXg1Ef04UqJCJ03AeJv8Ap5U6sfB6kNnxvcfw130_head.
- NP1216409.RABMGkE9CXg1Ef04UqJCJ03AeJv8Ap5U6sfB6kNnxvcfw130_assertion description "[In multivariate analysis, concomitant use of fluconazole for candidiasis was the only factor associated with reduced risk for hepatotoxicity (adjusted odds ratio, 0.372; 95% confidence interval, 0.145-0.957), while serostatus of hepatitis B or C virus, NAT1 and NAT2 acetylator types, or receipt of combination antiretroviral therapy was not.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1216409.RABMGkE9CXg1Ef04UqJCJ03AeJv8Ap5U6sfB6kNnxvcfw130_provenance.
- NP1216409.RABMGkE9CXg1Ef04UqJCJ03AeJv8Ap5U6sfB6kNnxvcfw130_assertion evidence source_evidence_literature NP1216409.RABMGkE9CXg1Ef04UqJCJ03AeJv8Ap5U6sfB6kNnxvcfw130_provenance.
- NP1216409.RABMGkE9CXg1Ef04UqJCJ03AeJv8Ap5U6sfB6kNnxvcfw130_assertion SIO_000772 25184238 NP1216409.RABMGkE9CXg1Ef04UqJCJ03AeJv8Ap5U6sfB6kNnxvcfw130_provenance.
- NP1216409.RABMGkE9CXg1Ef04UqJCJ03AeJv8Ap5U6sfB6kNnxvcfw130_assertion wasDerivedFrom befree-2016 NP1216409.RABMGkE9CXg1Ef04UqJCJ03AeJv8Ap5U6sfB6kNnxvcfw130_provenance.
- NP1216409.RABMGkE9CXg1Ef04UqJCJ03AeJv8Ap5U6sfB6kNnxvcfw130_assertion wasGeneratedBy ECO_0000203 NP1216409.RABMGkE9CXg1Ef04UqJCJ03AeJv8Ap5U6sfB6kNnxvcfw130_provenance.